Michael P Coleman Selected Research

Michael P Coleman Research Topics

Disease

24	Wallerian Degeneration 02/2022 - 02/2002
7	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 03/2003
6	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 12/2003
4	Peripheral Nervous System Diseases (PNS Diseases) 10/2021 - 01/2012
4	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 08/2011
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 04/2007
2	Polyneuropathies (Polyneuropathy) 10/2021 - 10/2019
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2021 - 04/2011
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 12/2018
2	Inflammation (Inflammations) 05/2019 - 01/2016
2	Tauopathies 03/2016 - 03/2012
2	Neoplasms (Cancer) 01/2016 - 12/2004
2	Glaucoma 09/2008 - 04/2007
1	Zika Virus Infection 01/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2021
1	Hereditary Spastic Paraplegia 01/2021
1	type 1 Pena Shokeir syndrome 10/2019
1	Erythromelalgia (Erythermalgia) 10/2019
1	Neuroinflammatory Diseases 05/2019
1	Infections 01/2019
1	Cognitive Dysfunction 01/2018
1	Ganglion Cysts (Ganglion) 11/2016
1	Hyperglycemia 08/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2015
1	Hypoglycemia (Reactive Hypoglycemia) 08/2015
1	Huntington Disease (Huntington's Disease) 08/2011
1	Peripheral Nerve Injuries 04/2011
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 04/2007
1	Wounds and Injuries (Trauma) 02/2006
1	Retrograde Degeneration 12/2003

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2004
8	NAD (NADH)IBA 02/2022 - 01/2012
5	EnzymesIBA 01/2020 - 04/2011
3	Pharmaceutical PreparationsIBA 01/2020 - 12/2004
2	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2022 - 11/2021
2	Biological ProductsIBA 10/2021 - 10/2021
2	ParvalbuminsIBA 01/2021 - 01/2018
2	Nicotinamide-Nucleotide AdenylyltransferaseIBA 10/2019 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 04/2007
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2016 - 03/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2013 - 12/2003
2	Protein Isoforms (Isoforms)IBA 01/2010 - 03/2003
1	Glycoside Hydrolases (Endoglycosidases)IBA 02/2022
1	TubulinIBA 01/2022
1	tau Proteins (tau Protein)IBA 12/2021
1	Carisoprodol (Soma)FDA LinkGeneric 01/2021
1	Amyloid beta-PeptidesIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2019
1	LipopolysaccharidesIBA 05/2019
1	Leucine (L-Leucine)FDA Link 01/2019
1	NucleotidesIBA 01/2019
1	P7C3-A20IBA 12/2018
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2018
1	nicotinamidenucleotide amidaseIBA 03/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2016
1	Glucagon (Glukagon)FDA Link 08/2015
1	Insulin (Novolin)FDA Link 08/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2015
1	Adenosine Triphosphate (ATP)IBA 04/2015
1	BIX 02189IBA 01/2013
1	U 0126 (UO 126)IBA 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2013
1	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 01/2013
1	IsoenzymesIBA 01/2012
1	Myelin ProteinsIBA 04/2011
1	Niacinamide (Nicotinamide)FDA LinkGeneric 04/2011
1	polyglutamineIBA 04/2007
1	Apolipoprotein E4IBA 04/2007
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2006
1	Nicotinamide MononucleotideIBA 02/2006
1	glutamine-synthetase adenylyltransferaseIBA 02/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	ProdrugsIBA 12/2004
1	CilengitideIBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	N-acetyltalosaminuronic acid (NAT)IBA 03/2004
1	HydrolasesIBA 12/2003
1	UbiquitinIBA 12/2003
1	Annexin A5IBA 06/2003
1	Messenger RNA (mRNA)IBA 03/2003

Therapy/Procedure

5	Axotomy 10/2006 - 02/2002
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2020
1	Therapeutics 02/2006